Table 3.
Change in laboratory findings after corticosteroid use
| Early use group (n = 12) | Late use group (n = 10) | |||||||
|---|---|---|---|---|---|---|---|---|
| Day 0 | Day 3 | Day 7 | Day 14 | Day 0 | Day 3 | Day 7 | Day 14 | |
| WBC count, cells/μL | 7496.67 ± 4065.33 | 9083.33 ± 3157.70 | 11,343.64 ± 5408.91 | 9762.00 ± 3989.17 | 8330.00 ± 2953.13 | 9738.00 ± 2988.52 | 12,063.00 ± 3200.34 | 10,045.56 ± 4728.95 |
| Neutrophil count, cells/μL | 706.75 ± 3451.137 | 7999.33 ± 2943.50 | 9954.64 ± 5162.74 | 7918.40 ± 4030.34 | 6918.10 ± 2844.49 | 6878.24 ± 2988.34 | 10,142.90 ± 3488.86 | 8444.31 ± 4657.33 |
| Lymphocyte, cells/μL | 756.77 ± 280.28 | 653.5 ± 247.79 | 830.20 ± 525.49 | 901.80 ± 446.39 | 774.86 ± 31.49 | 778.2 ± 535.66 | 906.40 ± 640.20 | 803.22 ± 451.07 |
| LDH, IU/L | 444.30 ± 113.95 | 366.75 ± 99.70 | 363.63 ± 95.43 | 339.43 ± 179.34 | 394.63 ± 126.97 | 463.60 ± 201.04 | 402.63 ± 157.78 | 367.50 ± 200.63 |
| Ferritin, ng/mL | 1423.8 ± 1047.96 | 966.08 ± 765.58 | 841.28 ± 465.38 | 1236.91 ± 975.47 | 1045.37 ± 895.92 | 1252.22 ± 1166.20 | 698.31 ± 167.39 | 813.22 ± 420.80 |
| CRP, mg/L | 16.83 ± 9.76 | 6.25 ± 7.93 | 2.95 ± 6.28 | 3.40 ± 3.44 | 15.42 ± 8.97 | 6.61 ± 3.18 | 2.33 ± 1.58 | 4.70 ± 2.34 |
| Procalcitonin, ng/mL | 0.33 ± 0.28 | 0.49 ± 0.47 | 0.17 ± 0.13 | 0.15 ± 0.25 | 0.54 ± 0.95 | 0.23 ± 0.11 | 0.11 ± 0.03 | 0.11 ± 0.06 |
| PaO2/FiO2 ratio | 124.89 ± 42.60 | 143.42 ± 57.61 | 157.70 ± 75.48 | 261.09 ± 134.38 | 133.35 ± 49.40 | 220.97 ± 45.61 | 183.40 ± 29.92 | 232.77 ± 138.59 |
| Ct value | 24.77 ± 8.42 | 27.31 ± 5.91 | 29.3 ± 8.85 | 32.73 ± 5.71 | 31.5 ± 3.07 | 24.53 ± 1.31 | 28.30 ± 7.14 | 35.40 ± 2.46 |
WBC white blood cell, LDH lactate dehydrogenase, CRP C-reactive protein, Ct value cycle threshold
Data are expressed as mean ± SD